Shanghai Pharma Biotherapeutics

Shanghai Pharma Biotherapeutics is a specialized biopharmaceutical subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), focused on the research, development, and commercialization of innovative biologics. The company operates a comprehensive value chain that includes discovery, clinical development, and large-scale GMP manufacturing for therapeutic antibodies and recombinant proteins. Its portfolio primarily targets high-unmet-need areas in oncology and immunology, featuring a mix of biosimilars and novel innovative drugs. By leveraging the extensive resources of its parent group, Shanghai Pharma Biotherapeutics aims to become a leading global player in the biopharmaceutical sector through strategic partnerships and internal innovation.